FourThought Financial Partners’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10M | Buy |
143,455
+41,785
| +41% | +$2.92M | 0.99% | 34 |
|
|
2025
Q1 | $7.47M | Buy |
101,670
+11,814
| +13% | +$868K | 0.78% | 41 |
|
|
2024
Q4 | $5.89M | Buy |
89,856
+1,844
| +2% | +$121K | 0.61% | 45 |
|
|
2024
Q3 | $6.86M | Sell |
88,012
-846
| -1% | -$65.9K | 0.81% | 44 |
|
|
2024
Q2 | $6.93M | Buy |
88,858
+115
| +0.1% | +$8.97K | 0.89% | 39 |
|
|
2024
Q1 | $6.01M | Buy |
88,743
+28,321
| +47% | +$1.92M | 0.69% | 45 |
|
|
2023
Q4 | $4.07M | Buy |
60,422
+2,633
| +5% | +$177K | 0.51% | 55 |
|
|
2023
Q3 | $3.91M | Buy |
57,789
+3,234
| +6% | +$219K | 0.55% | 52 |
|
|
2023
Q2 | $3.9M | Buy |
54,555
+4,309
| +9% | +$308K | 0.51% | 57 |
|
|
2023
Q1 | $3.49M | Buy |
50,246
+584
| +1% | +$40.5K | 0.48% | 63 |
|
|
2022
Q4 | $3.37M | Buy |
+49,662
| New | +$3.37M | 0.49% | 57 |
|